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Recent evidence suggests that endothelial dysfunction and pathol-
ogy of pulmonary vascular responses may serve as a precursor to
smoking-associated emphysema. Although it is known that emphy-
sematous destruction leads to vasculature changes, less is known
about early regional vascular dysfunction which may contribute to
and precede emphysematous changes. We sought to test the
hypothesis, via multidetector row CT (MDCT) perfusion imaging,
that smokers showingearly signs of emphysema susceptibility have
a greater heterogeneity in regional perfusion parameters than
emphysema-free smokers and persons who had never smoked
(NS). Assuming that all smokers have a consistent inﬂammatory
response, increased perfusion heterogeneity in emphysema-
susceptible smokerswould be consistentwith the notion that these
subjects may have the inability to block hypoxic vasoconstriction in
patchy, small regions of inﬂammation. Dynamic ECG-gated MDCT
perfusion scans with a central bolus injection of contrast were
acquired in 17 NS, 12 smokers with normal CT imaging studies
(SNI), and 12 smokers with subtle CT ﬁndings of centrilobular
emphysema (SCE). All subjects had normal spirometry. Quantitative
image analysis determined regional perfusion parameters, pulmo-
nary bloodﬂow (PBF), andmean transit time (MTT).Mean and coef-
ﬁcient of variationwere calculated, and statistical differences were
assessed with one-way ANOVA. MDCT-based MTT and PBF meas-
urementsdemonstrateglobally increasedheterogeneity in SCE sub-
jects comparedwith NS and SNI subjects but demonstrate similarity
between NS and SNI subjects. These ﬁndings demonstrate a func-
tional lung-imaging measure that provides a more mechanistically
oriented phenotype that differentiates smokers with and without
evidence of emphysema susceptibility.
pulmonary circulation | chronic obstructive pulmonary disease | pulmonary
emphysema | computed tomography | hypoxic pulmonary vasoconstriction
Multidetector rowCT(MDCT), alongwith thedevelopmentofquantitative image analysis techniques, provides a compre-
hensive assessment of the lung (1–3). MDCT imaging has focused
on evaluating the extent and distribution of emphysema, a subset
of chronic obstructive pulmonary disease (COPD). In this paper,
we focus speciﬁcally on smoking-associated emphysema. COPD is
characterized by a progressive airﬂow limitation associated with an
abnormal inﬂammatory response to noxious gases or particles and
leads to irreversible damage in the airways with enlargement of the
distal airspaces (4, 5). Although pulmonary hypertension is a well-
known clinical feature of advanced COPD (6, 7), less is known
about the vascular response and tone early in COPD pathogenesis.
Recent evidence suggests that endothelial dysfunction and alter-
ations in pulmonary vascular response occur early in COPD and
may represent an important vascularpathway in thedevelopmentof
smoking-associated emphysema (8–10). In response to cigarette
smoke, the lung reacts with the expansion of inﬂammatory cells.
With inﬂammation, alveoli often are ﬂooded, leading to regional
hypoxia. The lung’s normal response to alveolar hypoxia is hypoxic
pulmonary vasoconstriction (HPV) resulting in the shunting of
blood toward better-ventilated lung regions for improved oxygen-
ation. In sheep (11) and humans (12, 13), imaging demonstrates
thatHPV is blocked in the presence of inﬂammation, and this block
can be limited to the sites of inﬂammation (3). We therefore have
hypothesized (3) that if inherent mechanisms fail to block theHPV
response in the presence of inﬂammation, the inﬂammatory
response may not be self-limited by the normal cascade of events
and repair mechanisms, including delivery of bonemarrow-derived
progenitor cells (14, 15), thus leading to chronic inﬂammation, focal
tissue destruction, and emphysema.
Mishima et al. (16) previously provided a hypothesis and quan-
titative, CT-based evidence suggesting that local mechanical
weakening of the lung serves to promote progression of emphy-
sema once the disease is established. In this paper, we hypothesize
an underlying cause for the initial pathologic process and provide
quantitative, functional MDCT-based evidence supporting the
hypothesis. Dynamic 4D ECG-gated MDCT perfusion sequences
are tailored to determine quantitatively regional perfusion param-
eters, i.e., pulmonary blood ﬂow (PBF) and mean transit time
(MTT), through thedetectionof temporal changes in thedensity of
the lung parenchyma resulting from a rapid, central i.v. bolus
injection of iodinated contrast coupled with the application of
indicator dilution theory and ﬁrst-pass kinetics (17–20). We
hypothesize that increased heterogeneity (larger regional varia-
tion) of PBFandMTTwill exist in smokerswith normal spirometry
and MDCT-only ﬁndings of emphysema. This hypothesis is based
on the notion that smokers susceptible to emphysema may fail to
block HPV in the presence of inﬂammation, leading to increased
heterogeneity of MTT, whereas smokers not susceptible to
emphysema would block HPV in inﬂamed regions, maintaining a
more homogenous PBFandMTT. In this studywe formed a cohort
of subjects to determine the normal range of MDCT perfusion
parameters for subjects who had never smoked (NS) and then
compared these results with ﬁndings in a smoking population split
into two groups, thosewith (SCE) andwithout (SNI) subtleMDCT
evidence of centrilobular emphysema as detected visually by an
expert chest radiologist.
Results
Subject Characteristics. Forty-eight subjects underwent perfusion
MDCT imaging; seven subjects were excluded from the ﬁnal cohort
(two NS with bronchiectasis, one NS with emphysema on MDCT,
one smoker with a large mediastinal mass, one smoker with respi-
ratory alveolitis, and two subjects with contrast-injection errors).
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The remaining 41 subjects were categorized based on smoking
status (NS or smoker), and current smokers were subcategorized
further into two distinct groups, SCE and SNI, based on the pres-
ence (or absence) of emphysema onMDCTdetermined by a blind-
read from an expert chest radiologist with 15 years’ experience.
Baseline demographics, the diffusing capacity of the lung for carbon
monoxide (DLCO), and spirometrymeasurements for theNS, SNI,
and SCE groups are summarized in Table 1. None of the subjects
had ground-glass opacities in the region of perfusion MDCT
imaging. Of the 24 smokers imaged, 12 (50%) demonstrated
emphysema on MDCT. Six of these 12 subjects had upper lobe
emphysema only, two had upper and middle lobe emphysema, and
four had emphysema present in all lobes. Two subjects had bullous
changes. Compared with NS and SNI subjects, SCE subjects were
collectively older and had a greater number of pack-years, and their
prebronchodilator forced expiratory volume in 1 second/forced
vital capacity (FEV1/FVC) ratios were in the lower range of normal
(70–80% of predicted). However, there was overlap between the
groups. No signiﬁcant differences in spirometry measurements
existed between groups. DLCO measurements for SCE subjects
were signiﬁcantly decreased compared with those for NS but not
compared with those for SNI subjects (P= 0.02).
Volumetric CT. TheCT-based emphysema index (EI, the proportion
of lung volume below a threshold attenuation compared with the
total volume of the lung), α [an index of hole-size distribution
based on the measurements of Mishima et al. (16) and described
in Methods], and mean lung density are summarized in Table 1.
Although visual inspection served to divide the smokers into a
group with apical, centrilobular emphysema and a group with
normal imaging appearances, there were no signiﬁcant differences
between groups for whole-lung EI or αmeasurements obtained at
thresholds of−950Hounsﬁeld units (HU) (EI: P=0.4; α: P= 0.6)
or −910 HU (EI: P = 0.3; α: P = 0.3). To determine the extent
of emphysema speciﬁcally in the lung region imaged for perfusion,
the lungwas divided into thirds based on the distance from the apex
to the costophrenic angle. EI analyses were performed on the
middle third of the lung (covering the lung volume distal to the
carina and ending near the diaphragm); this area corresponded to
the region of perfusion imaging in all subjects. These EI meas-
urements for the three groups did not demonstrate differences
in the percent of emphysema-like lung with thresholds of−950HU
(P = 0.3) or −910 HU (P = 0.2). The mean percentages of
emphysema-like volume for themiddle third below−950HUwere
6.7%, 4.1%, and 4.0%, and those below −910 HU were 37.2%,
29.6%, and 26.5% for NS, SNI, and SCE subjects, respectively.
MDCT-Based Pulmonary Perfusion Parameters. An example of per-
fusion data obtained from an SNI subject (Fig. 1) demonstrates
time–attenuation curves obtained for the input arterial region of
interest (ROI) and ROIs placed in the nondependent and depend-
ent region of the lung parenchyma. PBF and MTT measurements
for NS, SNI, and SCE subjects were determined for the whole
imaged slab and are summarized in Table 2.
Whole lung. Absolute mean PBF (mL/100 mL/min) and MTT (sec-
onds) were determined for each group, and no statistically sig-
niﬁcant differences were found among the three groups for either
PBF (P = 0.8) or MTT measurements (P = 0.2). The one-way
ANOVA demonstrated signiﬁcant differences in coefﬁcient of
variation (CV) measurements for MTT between the groups (P =
0.0005),withposthoc analysis demonstrating signiﬁcantdifferences
inMTTCVmeasurements between the SCE group compared with
the SNI and NS groups but no signiﬁcant difference between the
SNI and NS groups. Similarly, for PBF CVmeasurements the one-
way ANOVA demonstrated signiﬁcant differences in CV meas-
urements between the groups (P = 0.0007) with post hoc analysis
demonstrating a signiﬁcant increase in CV in the SCE group com-
pared with the SNI and NS groups but no signiﬁcant difference
between the SNI and NS groups. A representative PBF and MTT
color map from a subject from each group demonstrates this dif-
ference inheterogeneity (Fig. 2).After accounting for differences in
subject age, signiﬁcant differences in CV in PBF (P = 0.02) and
MTT (P = 0.02) still exist among groups. After accounting for
subject age and pack-year smoking history speciﬁcally in the
smoking population, the differences in CV between the SNI and
SCE groups were diminished to a level of marginal nonsigniﬁcance
for PBF (CV: P=0.11) but were still signiﬁcant forMTT (CV: P=
0.015). Because of concern that the use of different models of
MDCT scanners might inﬂuence the observed differences in CV
measurements, a subgroup of perfusion images from 10 NS and
10 SCE subjects, all performed on the 64-slice scanner, were com-
pared, and signiﬁcant CV differences for PBF and MTT were
observed, similar to ﬁndings in the larger population.
Nondependent and dependent comparison.Regional data are graphed
in Fig. 3. MTT measurements did not vary signiﬁcantly through the
lung volume sampled. No signiﬁcant differences were observed
in mean MTT in nondependent, dependent, and whole-lung MTT
measurements. PBF measurements demonstrate an increasing
ﬂow gradient from nondependent to dependent regions of the lung
in all three groups. CV measurements of PBF and MTT exhibit
signiﬁcantly higher CV in the nondependent region than in the
dependent region for NS subjects (PBF: P = 0.0001; MTT: P =
0.00001), SNI subjects (PBF: P= 0.003; MTT: P= 0.001) and SCE
subjects (PBF: P= 0.001; MTT: P= 0.007).
Table 1. Characteristics of subjects
Characteristic NS SNI SCE
N 17 12 12
Gender (% male) 35 58 58
Age (years) 31 ± 10 32 ± 14 46 ± 11
BMI (kg/m2) 24 ± 3 25 ± 3 25 ± 4
Heart rate (bpm) 68 ± 10 72 ± 11 70 ± 13
Blood pressure (mm Hg)
Systolic 116 ± 13 119 ± 15 128 ± 13
Diastolic 66 ± 11 65 ± 12 74 ± 7
Creatinine (mg/dL) 0.8 ± 0.1 0.8 ± 0.1 1.0 ± 0.2
Pack-years — 15 ± 14 31 ± 15
Age started smoking (years) — 17 ± 3 16 ± 4
BDI 11.9 ± 0.2 11.3 ± 1.2 11.2 ± 1.3
Daily cough in past
2 weeks (%)
6 33 50
Prebronchodilator
FEV1 (%)
98.3 ± 8.9 84.9 ± 16.7 98.2 ± 23.5
Prebronchodilator
FVC (%)
100.7 ± 10.5 91.7 ± 11.5 103.9 ± 15.6
Prebronchodilator
FEV1/FV ()%
81.4 ± 7.0 77.2 ± 11.6 74.5 ± 4.9
DLCO (%) 92.7 ± 16.0 79.4 ± 10.4 75.7 ± 19.6
MLD (HU) −849 ± 36 −848 ± 18 −846 ± 21
EI −950 HU (%) 6.3 ± 5.9 4.1 ± 4.3 4.3 ± 3.8
EI −910 HU (%) 34.8 ± 16.9 28.3 ± 14.9 26.0 ± 12.5
α −950 HU 1.7 ± 0.3 1.7 ± 0.2 1.6 ± 0.4
α −910 HU 0.9 ± 0.4 1.1 ± 0.4 1.0 ± 0.2
Results are expressed as mean ± SD unless noted. Spirometry and DLCO is
reported as percent predicted. BDI, baseline dyspnea index; BMI, body mass
index; DLCO, diffusing capacity of the lung for carbon monoxide; EI, emphy-
sema index; FEV1, forced expiratory volume in 1 second; FVC, forced vital
capacity; MLD, mean lung density; NS, persons who had never smoked; SCE
smokers with centralobular emphysema present on MDCT; SNI, smokers with
normal CT imaging studies.
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Discussion
The data from this study suggest that heterogeneity of ﬂow may
serve as a functional “phenotype” of smoking-related centrilobular
emphysema. We assume that all smokers have the same inﬂam-
matory events, but in this study the SCE group, who are hypothe-
sized to have anHPV response associated with inﬂammation, have
signiﬁcantly patchier perfusion parameters, and the SNI group,
who are hypothesized to block HPV in inﬂamed regions, do not
show an increased CV of perfusion parameters relative to the NS
group, who do not have the smoking-related inﬂammatory events.
Interestingly, although DLCO was within a lower range of normal
for both smoking groups, the SCE group showed a signiﬁcant dif-
ference inDLCO comparedwith theNS group, but NS vs. SNI and
SNI vs. SCE DLCO values were not signiﬁcantly different from
each other. This ﬁnding is not surprising, because both groups were
likely to have inﬂamed lung regions. Theperfusionﬁndings support
our hypothesis that failure to block HPV with local inﬂammation
may serve as a precursor to destruction in a smoking population
susceptible to emphysema (and may be genetically based). It is
known that, in response to noxious particles and gases in cigarette
smoke, the lung reacts by recruiting inﬂammatory cells. Pulmonary
vascular changes characterized by a thickening of the vessel wall
have been characterized early in the history of COPD (21, 22).
More recently it has been observed that, in the presence of
inﬂammation, there is an enhanced delivery of progenitor cells to
the lung (14, 15). Remy-Jardin et al. (23) observed an increased
propensity for the lung to develop emphysema in regions charac-
terized by ill-deﬁned ground-glass opacities and micronodules
characteristic of inﬂammation. There are also suggestions in the
literature that, in response to inﬂammatory processes, the HPV
response normally is blocked (12, 13). In a sheep model, Easley
et al. (11) usedMDCT to demonstrate the regional failure of HPV
in a lung region ﬂooded with endotoxin but not with saline, and
Hoffman et al. (3) showed the coexistence of an intact HPV in
normal lung regions and a failure of HPV in inﬂamed lung regions.
If HPV shuts down blood ﬂow in an emphysema-susceptible
smoking population (increased CV of perfusion parameters), this
response would tend to shut down the cascade of events serving to
resolve an inﬂammatory event, including the blockade of progen-
itor cells that would serve to repair the damage caused by the
inﬂammatory response. Furthermore, if increased vascular tone in
an inﬂamed region is a critical event in the development of
emphysema, this increased vascular tone would have greater con-
sequences in the lung apex where blood ﬂow is further compro-
mised in the upright body posture because of gravitational effects,
explaining the predominance of apical pathology in smoking-
related emphysema. Barr and colleagues (24, 25) recently have
demonstrated a correlation between impaired left ventricular (LV)
ﬁlling and percent emphysema in groups of nonsmokers, ex-
smokers, and current smokers. The correlation between impaired
LV ﬁlling with emphysema was greater in current smokers than in
former smokers, consistent with the notion that increased vascular
resistance in inﬂamed lung regions of smokers susceptible to
emphysema may contribute to the LV-ﬁlling defect.
Another possible explanation of the current study’s ﬁndings is
that the increased PBF and MTT heterogeneity result from
microvascular destruction caused by microemphysema (including
very peripheral destruction of vascular and airway structures)
undetectable with the resolution of MDCT or, as has been sug-
gested recently, early destruction of peripheral airways (26). If such
microvascular or peripheral airways destruction was present in
our population, neither theαmeasurenor thedensitymask indexof
emphysema served as an index of this destruction. Loss of
peripheral pulmonary capillary beds because of parenchymal
destruction is a known feature of advanced disease (21) but has not
Table 2. MDCT-based perfusion parameters
Parameter NS SNI SCE
PBF(mL/100 mL/min)
Mean ± SD 221.5 ± 55.6 226.0 ± 47.5 210.3 ± 83.7
Range (low–high) 132.9–323.6 152.0–307.2 140.1–420.2
CV 0.43 ± 0.07 0.45 ± 0.11 0.58 ± 0.12
MTT (seconds)
Mean ± SD 4.68 ± 1.01 4.54 ± 0.70 4.08 ± 0.88
Range (low–high) 3.34–6.36 3.21–5.47 2.02–5.21
CV 0.45 ± 0.09 0.44 ± 0.08 0.58 ± 0.10
Results are expressed as mean ± SD unless noted. MTT, mean transit time;
NS, persons who had never smoked; PBF, pulmonary blood ﬂow; SCE, smok-
ers with emphysema present on MDCT; SNI, smokers with normal MDCT
imaging studies.
Fig. 1. Dynamic time–attenuation curve data for an SNI subject. Graphs
show corresponding time–attenuation curves demonstrating the dynamic
change in HU as the bolus of contrast passes through the PA (Upper) and
through the dependent and nondependent regions of the lung parenchyma
(Lower). Regional PBF and MTT are obtained by applying indicator dilution
theory to the data. (Inset) MDCT perfusion baseline image.
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been demonstrated in transformational regions. If our ﬁndings
were the result of very peripheral disease that was undetectable by
purely anatomy-basedmetrics on theMDCT image, these ﬁndings
would indicate that functional imaging provides a differentiating
phenotype, whereas anatomical imaging with MDCT provides no
differences including quantitative measures of emphysema-like
lung at a threshold of either −950 or −910 HU. Regardless of the
underlying mechanism (failure to block HPV in the presence of
inﬂammation or microdestruction with loss of peripheral vascular
and airway structures), the increased CV of MTT and PBF meas-
urements in this population identiﬁes a mechanistic phenotype
differentiating our NS and SNI subjects from our SCE subjects.
Currently, both density and airways changes are considered to be
the primary imaging-based phenotypes serving to differentiate
COPD groups (27–29). We describe a functionally based, image-
derived phenotype (CV of PBF and MTT) within regions of lung
with no density-based changes, and this phenotype may link more
closely to speciﬁc disease etiology.
Our cohort consisted of individuals with normal spirometry and
with no clear differences in MDCT densitometric-based emphy-
sema measurements between groups, indicating a population of
smokers with preclinical emphysema. The SCE group had sig-
niﬁcantly lower DLCO, and the SNI group trended toward lower
DLCO as compared with the NS group, suggesting that inﬂam-
matory processes were present in the smokers. The presence of
emphysema, mainly in the apical lobes, did not typically corre-
spond to the region of lung sampled for perfusion imaging.
Therefore, the increased heterogeneity demonstrated in smok-
ers susceptible to emphysema is not simply the result of gross
parenchymal destruction.
We also explored the relationship of perfusion in the non-
dependent and dependent regions of the lung, demonstrating an
increasing blood ﬂow gradient in the supine position consistent
with gravitational forces ﬁghting perfusion, most likely in zones
2 and 3 (30). This gradient is present in all groups and therefore did
not relate to smoking status. The gradient is consistentwith reports
in the literature from CT (18), MR (31–34) and PET (35, 36)
imaging modalities. The high spatial resolution perfusion maps
obtained with MDCT perfusion imaging demonstrated regional
heterogeneity in the lung parenchyma. When quantiﬁed by CV
measurements, an increased heterogeneity was demonstrated in
the nondependent region comparedwith the dependent region for
Fig. 3. MTT and PBF measurements (mean ± SEM) for depend-
entandnondependent regionsofthe lung. (A)MeanMTTdidnot
differ between the nondependent and dependent regions for
any of the groups. (B) In all three groups, mean normalized PBF
measurements demonstrate increased ﬂow in the dependent
region and decreased ﬂow in the nondependent region of the
lung. (C) In all three groups the CV of MTT is increased in the
nondependent region comparedwith the dependent region. (D)
In all three groups the CV of mean normalized PBF is greater in
the nondependent region than in the dependent region.
Fig. 2. Color-coded maps of perfusion parameters
overlaid on an imaging slice for a subject in each
group. (A) MTT maps for NS (Left), SNI (Center), and
SCE (Right) subjects. Maps demonstrate signiﬁcantly
increased regional heterogeneity of MTT measure-
ments in SCE subjects as compared with NS and SNI
subjects. Range: 0–8 seconds. (B) PBF normalized to
the mean PBF for NS (Left), SNI (Center), and SCE
(Right) subjects. As inMTTﬁndings, there is increased
regional heterogeneity in mean normalized PBF
measurements in SCE subjects comparedwith NS and
SNI subjects. The range on the color scale for MTT is
0-8 seconds andthe range formeannormalizedPBF is
25–175%.
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both MTT and PBF measurements in all three groups. Smoking
status did not change this regional difference in heterogeneity
during supine imaging. We hypothesize that in the upright body
posture, the interplay between HPV in inﬂamed regions and
gravitational-based reduction of perfusion parameters may make
the lung apices more susceptible to events leading to the devel-
opment of emphysema (in the current investigation, to smoking-
related centrilobular emphysema).
This study is limited by its cross-sectional study design. A sub-
population of the SNI subjects might be susceptible to emphysema
not revealed by current imaging evidence. The SNI group tended
to be younger than the SCE subjects. Although there was a sig-
niﬁcant difference in our SCE population versus the NS and SNI
groups, there was overlap among the populations in regards to
MTT and PBF measures. SNI subjects with higher CV measure-
ments represent a group of potential interest regarding emphy-
sema susceptibility. Following the SNI smokers longitudinally to
assess if there is a correlation between higher CV measurements
and the development and progression of centrilobular emphysema
would facilitate such an evaluation.
The functional CT method used in this study captures 4D data
(3D volume plus time) at baseline and during a sharp bolus
injection of contrast, allowing the collection of time–intensity data
necessary for ﬁrst-pass kinetics. This protocol is not the standard
clinical protocol used to evaluate regional perfused blood volume
(slow prolonged bolus of contrast injected to cause a prolonged
enhancement of blood) but rather is tailored to provide quanti-
tative data regarding regional PBF (in mL/100 mL/min) andMTT
(in seconds). The perfusion scans were performed using axial
scanning to image amultislice slab of lung just below the carina and
cephalad to the diaphragm dome. This region was selected for
several reasons: (i) Large branches of the pulmonary arteries were
available for assessing the arterial input function used in the per-
fusion calculations, (ii) this region of lung was not visually or
quantitatively affected by emphysema, and (iii) we hypothesize
that the enhanced heterogeneity of perfusion will be present
everywhere in the lung, whereas apical emphysema is caused by
hypoxic pulmonary vasoconstriction confounded by the effects of
gravity over time. TheMDCTperfusion technique assesses a region
of lung corresponding to the z-axis coverage of the multidetector
scanner array. Various altered scanner designs may, in the future,
provide access to perfusion parameters over the whole lung. How-
ever, the partial lung coverage presented here is adequate for
phenotypic differentiation among smoking populations. Deriva-
tives of such imaging may ﬁnd clinical utility if subphenotype
selection becomes important for treatment selection or outcomes
assessment; initially, such imaging will aid in elucidating disease
etiology and drug and device discovery. Because there is a strong
relationship between regional vascular resistance and compliance
(37), one would expect there to be correlations between MDCT
measures of regional perfused pulmonary blood volume and pul-
monary perfusion parameters. Thus, simpler means of measuring
perfused pulmonary blood volume, requiring only a single volume
scan using dual-energy MDCT (38), may serve as a surrogate for
the imagingmethods outlined in this study. Furthermore,MRmea-
sures of regional perfusion (39) might provide similar measures of
perfusion heterogeneity.
In summary, perfusion MDCT imaging provides a minimally
invasive means of obtaining functional information about the
pulmonary vasculature and provides valuable information as we
continue to characterize a vascular phenotype of emphysema. Our
data show a blood ﬂow pattern of signiﬁcantly increased hetero-
geneity, indicative of increased regional variability in PBF and
MTT in a subset of smokers with minimal visual MDCT-based
evidence of centrilobular emphysema and normal spirometry.
These ﬁndings do not prove but are consistent with our hypothesis
that inﬂammation-based HPV occurs in smokers susceptible to
centrilobular emphysema but is blocked successfully in smokers
without signs of emphysema susceptibility. An alternative expla-
nation is that microdestruction that is undetectable by visual or
quantitative CT measures occurs in the region of lung in which
blood ﬂow measures were made. In either case, our functional
MDCT measures provide a functional phenotype that may be
mechanistic in nature and of importance in the differentiation of
patient populations as part of a search for genotypes associated
with COPD and other potentially genetic-based lung disease.
Methods
Study Population. From November 2004 to April 2008, 48 subjects were
recruited as part of an effort to establish a normative lung atlas. The Uni-
versity of Iowa institutional review board approved this study, and written
informed consent was obtained from all subjects before they entered the
study. Study inclusion criteria were “never smokers” (with a total smoking
history of less than 1 pack-year, NS) and smokers currently smoking one
pack per day. Exclusion criteria were known heart disease, kidney disease,
diabetes, presence ofmetal in the lungﬁeld, pregnancy, an X-ray/CT scan in
the past 12 months, contrast allergies, a glomerular ﬁltration rate less than
60 mL/min, and a body mass index over 32. NS with clinically important
pathology detected on MDCT were excluded, as were smokers with sig-
niﬁcant lung disease other than emphysema. The baseline dyspnea index
was determined (40). Prebronchodilator spirometry including DLCO
measurements were performed via a V6200 Body Box (SensorMedics) or an
OWL body plethysmograph (Ferraris Respiratory), veriﬁed for equivalency.
Spirometry quality followed the American Thoracic Society and European
Respiratory Society guidelines (41).
MDCT Imaging. Heart rate, ECG, arterial pressure, and pulse oximetry oxygen
saturation (SpO2) were monitored continuously (Philips IntelliVue patient
monitoring system,M8010A,) during imaging.MDCT imagingconsistedof spiral
noncontrast volumetric scans of the lung obtained during breath-hold at two
ﬁxed, spirometry-controlled lung volumes, functional residual capacity (FRC:
20% vital capacity) and total lung capacity (TLC: 100% of vital capacity), and a
dynamic ECG-gated perfusion scan performed at an FRC breath-hold. MDCT
scanners were upgraded throughout the study with each scanner’s perfusion
protocol selected to maximize the similarity of spatial resolution. Breath-holds
were obtained with the aid of a laboratory-developed lung volume controller
system that allowed the instantaneous measurement of airﬂow and airway
pressures and held lung volumes appropriately with the aid of a computer-
controlled balloon valve on the expiratory port. Volumetric MDCT scan times
were under 10 seconds with a z-coverage of 22–30 cm, adjusted to capture the
whole lung. Voxels were near isotropic at 0.47 mm × 0.47 mm × 0.5 mm. The
following imaging protocol was used with our 64-slice MDCT scanner: 100
milliampere-seconds (mAs), 120 kV, 1 mm pitch, 512 × 512 matrix, and B31f
reconstruction kernel. ECG-gated axial dynamic MDCT perfusion imaging
acquires 4D information on a volume of lung during the administration of a
sharp, central bolus (0.5 mL/kg, up to a total volume of 40 mL) of iodinated
contrast agent (Visipaque 350;GE Healthcare) delivered over 2 seconds by a
power injector (Mark V ProVis; MedRad) through a 5F percutaneously intro-
duced central line in the superior vena cava. Central line placement was per-
formedbya chest or interventional radiologistwith theaidofﬂuoroscopyat the
MDCT scanner. Perfusion is assessedwith subjects in the supinepositionduringa
breath-hold at FRC.We believe it is important to image at FRC because it is well
recognized that at higher lung volumes blood ﬂow is reduced in the non-
dependent lung regions. Images collected during a dynamic sequence consisted
of 11 (4-slice scanner) or 14 (16-slice or 64-slice scanners) time points including a
baseline followed by the bolus contrast injection as it ﬂowed through the lung
ﬁelds. Beta-blockers were not necessary to control heart rate. Scanner-based
perfusion imaging parameters are summarized in Table S1. The maximum
effective radiation dose (conservatively calculated) is 10.6 mSv for the volume
scans and 3.2 mSv for the perfusion scan.
Image Analysis.Mean lung density and an EI for thresholds of −950 and −910
HU were obtained from TLC images using Pulmonary Workstation software
(PW; VIDA Diagnostics) (42). Because images were obtained with three dif-
ferent scanners over the course of 4 years, EI thresholds were modiﬁed to
correct for interscan variation using the attenuation of air outside the body
and blood from the aorta. α, deﬁned as the negative slope of the cumulative
cluster–size distribution of areas with attenuation lower than a speciﬁed
threshold, was determined for thresholds of −950 HU and −910 by methods
described by Mishima et al. (16). PBF and MTT were determined using
indicator dilution theory with Pulmonary Analysis Software Suite (PASS), a
laboratory-developed software program (2, 43). Segmented lung paren-
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chymal voxels were binned in 3 × 3 ROIs (1.4 mm × 1.4 mm × 1.2 mm)
resulting in regional data for 2.4 mm3. Regional PBF and MTT measurements
were determined based on time–attenuation curves for lung parenchyma
ROIs, assuming a bolus injection, residue detection model (17, 19, 20). In this
model, PBF is deﬁned as the ratio of change in HU to the area under the
input time–attenuation arterial curve, and MTT is assessed as the area under
the residue curve divided by the maximum height. Data were ﬁltered to
remove major airways and vessels (ensuring ROIs were predominately lung
parenchyma) using the following criteria: fractional air content: 0.4–0.9;
fractional blood content: 0.02–0.5; and χ2 curve ﬁt: 0–200,000. To compare
regional differences across groups without intersubject variability from dif-
fering cardiac outputs, PBF was normalized to the mean PBF.
Statistical Analysis. SPSS (Windows 15.0, SPSS, Inc) was used for statistical
comparisons. Data are expressed as mean ± SD for the whole-lung volume and
the nondependent and dependent thirds of the lung. Nondependent and
dependent regions correspond to theupper and lower thirdsof the supine lung.
Heterogeneity of PBF andMTT is assessed by its CV. One-way ANOVA followed
by post hoc analysis using the Bonferroni method was used to determined
statistical differences, with a P value less than 0.05 considered signiﬁcant.
Additional analyses accounting for the subject’s age were performed to com-
pare CV between groups. Paired t tests assessed differences in the dependent
vs. nondependent regions.
ACKNOWLEDGMENTS. The authors thank Heather Baumhauer, Joanie
Wilson, and Angie Delsing for help with patient recruitment; Jered Sieren,
Lisa Hudson, and John Morgan for assistance during imaging; Dr. Shilang
Sun, Dr. Jafar Golzarian, and Dr. Steve Burke for their assistance in central
venous line placement; and Junfeng Guo for software assistance. This work
was funded by National Institutes of Health Grant R01 HL-064368 (toE.A.H.).
1. Hoffman EA, Chon D (2005) Computed tomography studies of lung ventilation and
perfusion. Proc Am Thorac Soc 2:492–498, 506.
2. Hoffman EA, et al. (2003) Characterization of the interstitial lung diseases via density-
based and texture-based analysis of computed tomography images of lung structure
and function. Acad Radiol 10:1104–1118.
3. Hoffman EA, Simon BA, McLennan G (2006) State of the art. A structural and
functional assessment of the lung via multidetector-row computed tomography:
Phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:519–532.
4. Barnes PJ (2000) Chronic obstructive pulmonary disease. N Engl J Med 343:269–280.
5. Rabe KF, et al.; Global Initiative for Chronic Obstructive Lung Disease (2007) Global
strategy for the diagnosis, management, and prevention of chronic obstructive
pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176:532–555.
6. Barberà JA, Peinado VI, Santos S (2003) Pulmonary hypertension in chronic obstructive
pulmonary disease. Eur Respir J 21:892–905.
7. Thabut G, et al. (2005) Pulmonary hemodynamics in advanced COPD candidates for
lung volume reduction surgery or lung transplantation. Chest 127:1531–1536.
8. Barr RG, et al. (2007) Impaired ﬂow-mediated dilation is associated with low pulmonary
function and emphysema in ex-smokers: The Emphysema and Cancer Action Project
(EMCAP) Study. Am J Respir Crit Care Med 176:1200–1207.
9. Kanazawa H, Asai K, Hirata K, Yoshikawa J (2003) Possible effects of vascular
endothelial growth factor in the pathogenesis of chronic obstructive pulmonary
disease. Am J Med 114:354–358.
10. McAllister DA, et al. (2007) Arterial stiffness is independently associated with
emphysema severity in patients with chronic obstructive pulmonary disease. Am J
Respir Crit Care Med 176:1208–1214.
11. Easley RB, FuldMK, Fernandez-Bustamante A, Hoffman EA, Simon BA (2006)Mechanism
of hypoxemia in acute lung injury evaluated by multidetector-row CT. Acad Radiol 13:
916–921.
12. Gust R, Kozlowski J, Stephenson AH, Schuster DP (1998) Synergistic hemodynamic
effects of low-dose endotoxin and acute lung injury. Am J Respir Crit Care Med 157:
1919–1926.
13. Schuster DP,Marklin GF (1986) The effect of regional lung injury or alveolar hypoxia on
pulmonary blood ﬂow and lung water measured by positron emission tomography.
Am Rev Respir Dis 133:1037–1042.
14. Peinado VI, Ramírez J, Roca J, Rodriguez-Roisin R, Barberà JA (2006) Identiﬁcation of
vascular progenitor cells in pulmonary arteries of patients with chronic obstructive
pulmonary disease. Am J Respir Cell Mol Biol 34:257–263.
15. Ishizawa K, et al. (2004) Bone marrow-derived cells contribute to lung regeneration
after elastase-induced pulmonary emphysema. FEBS Lett 556:249–252.
16. Mishima M, et al. (1999) Complexity of terminal airspace geometry assessed by lung
computed tomography in normal subjects and patients with chronic obstructive
pulmonary disease. Proc Natl Acad Sci USA 96:8829–8834.
17. Chon D, Beck KC, Larsen RL, Shikata H, Hoffman EA (2006) Regional pulmonary blood
ﬂow in dogs by 4D-X-ray CT. J Appl Physiol 101:1451–1465.
18. Dakin JH, Evans TW, Hansell DM, Hoffman EA (2008) Regional pulmonary blood ﬂow
in humans and dogs by 4D computed tomography. Acad Radiol 15:844–852.
19. Hoffman EA, Tajik JK, Kugelmass SD (1995) Matching pulmonary structure and
perfusion via combined dynamic multislice CT and thin-slice high-resolution CT.
Comput Med Imaging Graph 19:101–112.
20. Won C, et al. (2003) CT-based assessment of regional pulmonary microvascular blood
ﬂow parameters. J Appl Physiol 94:2483–2493.
21. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, GOLD Scientiﬁc Committee
(2001) Global strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive
Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163:1256–1276.
22. Wright JL, Churg A (2006) Advances in the pathology of COPD. Histopathology 49:
1–9.
23. Remy-Jardin M, et al. (2002) Longitudinal follow-up study of smoker’s lung with thin-
section CT in correlation with pulmonary function tests. Radiology 222:261–270.
24. Barr RG, et al. (2010) Percent emphysema, airﬂow obstruction, and impaired left
ventricular ﬁlling. N Engl J Med 362:217–227.
25. Vonk-Noordegraaf A (2010) The shrinking heart in chronic obstructive pulmonary
disease. N Engl J Med 362:267–268.
26. Hogg JC, McDonough JE, Gosselink JV, Hayashi S (2009) What drives the peripheral
lung-remodeling process in chronic obstructive pulmonary disease? Proc Am Thorac
Soc 6:668–672.
27. Coxson HO (2008) Quantitative computed tomography assessment of airway wall
dimensions: Current status and potential applications for phenotyping chronic
obstructive pulmonary disease. Proc Am Thorac Soc 5:940–945.
28. Coxson HO, Rogers RM (2005) Quantitative computed tomography of chronic
obstructive pulmonary disease. Acad Radiol 12:1457–1463.
29. Nakano Y, et al. (2002) Quantitative assessment of airway remodeling using high-
resolution CT. Chest 122 (6, Suppl)271S–275S.
30. West JB, Dollery CT, Naimark A (1964) Distribution of blood ﬂow in isolated lung;
Relation to vascular and alveolar pressures. J Appl Physiol 19:713–724.
31. Ley S, et al. (2007) Quantitative 3D pulmonary MR-perfusion in patients with
pulmonary arterial hypertension: Correlation with invasive pressure measurements.
Eur J Radiol 61:251–255.
32. Prisk GK, et al. (2007) Pulmonary perfusion in the prone and supine postures in the
normal human lung. J Appl Physiol 103:883–894.
33. Hopkins SR, et al. (2007) Vertical gradients in regional lung density and perfusion in
the supine human lung: The Slinky effect. J Appl Physiol 103:240–248.
34. Ohno Y, et al. (2004) Quantitative assessment of regional pulmonary perfusion in the
entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic
resonance imaging: Preliminary experience in 40 subjects. J Magn Reson Imaging 20:
353–365.
35. Schuster DP, Kaplan JD, Gauvain K, Welch MJ, Markham J (1995) Measurement of
regional pulmonary blood ﬂow with PET. J Nucl Med 36:371–377.
36. Musch G, et al. (2002) Topographical distribution of pulmonary perfusion and ventilation,
assessed by PET in supine and prone humans. J Appl Physiol 93:1841–1851.
37. Lankhaar JW, et al. (2006) Quantiﬁcation of right ventricular afterload in patients
with and without pulmonary hypertension. Am J Physiol Heart Circ Physiol 291:
H1731–H1737.
38. Pontana F, et al. (2008) Lung perfusion with dual-energy multidetector-row CT (MDCT):
Feasibility for the evaluation of acute pulmonary embolism in 117 consecutive patients.
Acad Radiol 15:1494–1504.
39. OhnoY, et al. (2007) Assessment of bolus injection protocol with appropriate concentration
for quantitative assessment of pulmonary perfusion by dynamic contrast-enhanced MR
imaging. J Magn Reson Imaging 25:55–65.
40. Mahler DA, Weinberg DH, Wells CK, Feinstein AR (1984) The measurement of dyspnea.
Contents, interobserver agreement, and physiologic correlates of two new clinical
indexes. Chest 85:751–758.
41. Miller MR, et al.; ATS/ERS Task Force (2005) Standardisation of spirometry. Eur Respir J
26:319–338.
42. Müller NL, Staples CA, Miller RR, Abboud RT (1988) “Density mask”. An objective
method to quantitate emphysema using computed tomography. Chest 94:782–787.
43. Guo J, Fuld MK, Alford SK, Reinhard JM, Hoffman EA (2008) Pulmonary Analysis
Software Suite 9.0: Integrating quantitative measures of function with structural
analyses. In Brown M, et al., eds, First International Workshop on Pulmonary Image
Analysis (New York) pp 283–292.
7490 | www.pnas.org/cgi/doi/10.1073/pnas.0913880107 Alford et al.
